Evidence map›Paper›PMID 37010413›Full record

ArticlemBio2023

Reed M Stubbendieck, Eishika Dissanayake, Peter M Burnham, Susan E Zelasko, Mia I Temkin, Sydney S Wisdorf, Rose F Vrtis, James E Gern, Cameron R Currie

Open access · goldAbstract read
In one paragraph

Article in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. International journal of systematic and evolutionary microbiology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The porcine skin microbiome exhibits broad fungal antagonism.Fungal genetics and biology : FG & B · 2024
    Article
  15. Understanding the influence of the microbiome on childhood infections.Expert review of anti-infective therapy · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Host microbiome-pathogen interactions in pediatric infections.Current opinion in infectious diseases · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Reed M StubbendieckDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0003-1507-3272
Eishika DissanayakeDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Peter M BurnhamDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Susan E ZelaskoDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Mia I TemkinDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Sydney S WisdorfDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Rose F VrtisDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
James E GernDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.ORCID 0000-0002-6667-4708
Cameron R CurrieDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0003-3104-3997
University of Wisconsin–Madison · USOklahoma State University · US

Funding

Novel antimicrobials targeting MDR pathogens from animal microbial symbiontsU19AI142720 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SAFDAR, NASIA · 2019 to 2023
$30.1M
Research Training for Computation and Informatics in Biology and MedicineT15LM007359 · NLM · UNIVERSITY OF WISCONSIN-MADISON · PI Mark W. Craven, Colin Noel Dewey · 2002 to 2026
$22.6M
Wisconsin Infant Study Cohort (WISC)U19AI104317 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI James E. Gern · 2013 to 2026
$22.5M
NRSA Training CoreTL1TR002375 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI Vivek Prabhakaran · 2017 to 2026
$8.4M
Integrated Training For Physician-ScientistsT32GM140935 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Anna Huttenlocher, Jeniel E Nett · 2021 to 2026
$6.5M
Identification of antimicrobial specialized metabolites from the human oral microbiome to target multidrug-resistant pathogensF30AI169759 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ZELASKO, SUSAN · 2023 to 2024
$79k
NCATS NIH HHS TL1 TR002375NIAID NIH HHS F30 AI169759NIAID NIH HHS U19 AI104317NIAID NIH HHS U19 AI142720NIGMS NIH HHS T32 GM140935NLM NIH HHS T15 LM007359
6 · The paper itself

Abstract

Moraxella catarrhalis is found almost exclusively within the human respiratory tract. This pathobiont is associated with ear infections and the development of respiratory illnesses, including allergies and asthma. Given the limited ecological distribution of M. catarrhalis, we hypothesized that we could leverage the nasal microbiomes of healthy children without M. catarrhalis to identify bacteria that may represent potential sources of therapeutics.

Indexed as

AsthmaMoraxella catarrhalisAdultChildEndopeptidasesHumansPeptidoglycanRespiratory SoundsEndopeptidasesPeptidoglycanpeptidoglycan endopeptidaseacute otitis mediaasthmaMoraxella catarrhalisnasal microbiomepeptidoglycan endopeptidaseRothiaRothia aeriaRothia dentocariosaRothia mucilaginosa

Identifiers

PMID37010413
PMCPMC10128031
OpenAlexW4362505920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.